Two Cases of Cytomegalovirus Pneumonia after CD34 Selected Autologous Stem Cell Transplantation
Korean Journal of Hematology
;
: 134-137, 2006.
Article
Dans Coréen
| WPRIM
| ID: wpr-720229
ABSTRACT
Cytomegalovirus (CMV) pneumonia is an important cause of treatment related mortality after allogeneic stem cell transplantation (SCT) and autologous SCT, particularly in a CD34 selected setting. There is little known about the immune reconstitution pertaining to the CMV after CD34 selected SCT. However, several studies have suggested there is more profound immunodeficiency early in the CD34 selected population compared with the unselected population. We encountered two fatal cases of CMV pneumonia at the CD34 selected SCT for T-cell lymphoblastic lymphoma and high-risk breast cancer that was confirmed through a lung biopsy and bronchoalveolar lavage. In conclusion, autologous CD34 selected CMV seropositive recipients need to be monitored in a similar manner to allogeneic recipients.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Pneumopathie infectieuse
/
Cellules souches
/
Biopsie
/
Tumeurs du sein
/
Lymphocytes T
/
Mortalité
/
Lavage bronchoalvéolaire
/
Cytomegalovirus
/
Transplantation de cellules souches
/
Leucémie-lymphome lymphoblastique à précurseurs B et T
Type d'étude:
Étude pronostique
langue:
Coréen
Texte intégral:
Korean Journal of Hematology
Année:
2006
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS